Anthropic invests $400 million in early-stage AI biotech startup, delivering massive returns to early investors

Anthropic is acquiring an eight-month-old biotech startup with fewer than ten employees for $400 million in shares

Early investors in the startup achieved a 38,513 percent return on their investment

The deal highlights major venture capital activity in the AI-powered drug discovery and pharmaceutical sector